Drugs

Excipients in tablets and other pharmaceutical formulations play varied roles depending on the intended purpose within the medicine, often necessitating distinct material properties to ensure effective results. The roles of excipients in drugs include facilitating manufacturing, aiding breakdown and absorption […]

Evolving Landscape of Excipients According to the International Pharmaceuticals Excipients Council, “Pharmaceutical excipients are essentially substances apart from the active pharmaceutical ingredient (API) that are rigorously tested for safety and deliberately incorporated into drug delivery systems to: Facilitate the drug

Despite boasting the globe’s third-largest pharmaceutical industry by volume and leading the production of generic drugs worldwide, India remains significantly reliant on China for sourcing raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs). With India producing approximately

India’s Growth in the Generic Medicine Sector India’s pharmaceutical industry stands as a testament to the country’s significant achievements in both branded and unbranded generic drugs. The pivotal Hathi Commission report of 1969 and the Indian Patents Act of 1970

The Indian pharmaceutical industry continues to garner attention due to its impressive feats in securing regulatory approvals and executing ambitious growth strategies. Industry insiders remain highly encouraged by the sector’s promising trajectory. Recognized for its significant potential in global healthcare,

Dizal, a pioneering biopharmaceutical enterprise focused on creating groundbreaking treatments for cancer and immune system ailments, has announced the release of a comprehensive analysis assessing sunvozertinib’s efficacy in non-small cell lung cancer (NSCLC) patients resistant to epidermal growth factor receptor

Provectus Biopharmaceuticals, Inc. (Provectus) has unveiled VisiRose, Inc. (VisiRose), marking its venture into founded entities. This newly established clinical-stage biotech firm is dedicated to advancing the commercialization of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) targeting infectious keratitis and other

Microbot Medical Inc, an innovative medical technology firm still in the pre-commercial phase, is dedicated to enhancing patient and provider care on a global scale. The company has developed the pioneering LIBERTY, a single-use endovascular robotic system, and has now

Eikonizo Therapeutics Gains Financial Backing from Novo Nordisk for Its Prime Candidate, EKZ-102 Eikonizo Therapeutics, a groundbreaking biopharmaceutical company committed to creating disease-altering treatments for those suffering from neurodegenerative and cardiorenal conditions, has declared a successful equity investment from Novo

Across the UK, patients will have increased access to innovative treatments and clinical trials with the announcement of a £100 million public-private investment aimed at establishing 20 research centres. Commercial Research Delivery Centres (CRDCs) are set to serve as regional